Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 4 Activity of protein kinase C (PKC). Myocardial PKC activity in the particulate fraction was increased in noninfarcted viable myocardium of the untreated myocardial infarction (MI) animals (MI/control [C]) compared with shams. Treatment of MI animals with candesartan (MI/angiotensin II type 1 receptor blocker [ARB]) reduced PKC activity in the particulate fraction, compared with MI/C. *p < 0.05 MI/C vs. sham;  p < 0.05 MI/ARB vs. MI/C; n = 5 in each group.
|
